99 related articles for article (PubMed ID: 2899894)
1. Radioimmunoassay for octapeptide analogs of somatostatin: measurement of serum levels after administration of long-acting microcapsule formulations.
Mason-Garcia M; Vaccarella M; Horvath J; Redding TW; Groot K; Orsolini P; Schally AV
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5688-92. PubMed ID: 2899894
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
Schally AV; Redding TW
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassay for 6-D-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum levels after administration of long-acting microcapsule formulations.
Mason-Garcia M; Vigh S; Comaru-Schally AM; Redding TW; Somogyvari-Vigh A; Horvath J; Schally AV
Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1547-51. PubMed ID: 3156381
[TBL] [Abstract][Full Text] [Related]
4. Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model.
Yano T; Pinski J; Szepeshazi K; Milovanovic SR; Groot K; Schally AV
Prostate; 1992; 20(4):297-310. PubMed ID: 1351672
[TBL] [Abstract][Full Text] [Related]
5. Delayed release formulation of the somatostatin analog RC-160 inhibits the growth hormone (GH) response to GH-releasing factor-(1-29)NH2 and decreases elevated prolactin levels in rats.
Bokser L; Schally AV
Endocrinology; 1988 Oct; 123(4):1735-9. PubMed ID: 2901338
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of receptors for somatostatin in various tumors using different analogs.
Srkalovic G; Cai RZ; Schally AV
J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467
[TBL] [Abstract][Full Text] [Related]
7. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
[TBL] [Abstract][Full Text] [Related]
8. Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules.
Zalatnai A; Schally AV
Cancer Res; 1989 Apr; 49(7):1810-5. PubMed ID: 2564312
[TBL] [Abstract][Full Text] [Related]
9. Development of a radioimmunoassay for a pseudononapeptide bombesin/GRP antagonist with antitumor activity.
Groot K; Horvàth JE; Cai RZ; Schally AV
Int J Pept Protein Res; 1995 Jun; 45(6):561-6. PubMed ID: 7558587
[TBL] [Abstract][Full Text] [Related]
10. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
Karashima T; Cai RZ; Schally AV
Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
[TBL] [Abstract][Full Text] [Related]
11. Effect of somatostatin analogs on gastric acid secretion in dogs and rats.
Schally AV; Colaluca J; Paulson D; Carter WH; Neitzschman HR; Lafaye H; Cai RZ
Int J Pept Protein Res; 1990 Sep; 36(3):267-74. PubMed ID: 1980670
[TBL] [Abstract][Full Text] [Related]
12. Development of radioimmunoassay for a potent luteinizing hormone-releasing hormone antagonist. Evaluation of serum levels after injection of [Ac-3-(2-naphthyl)-D-Ala1, D-Phe(pCl)2, 3-(3-pyridyl)-D-Ala3, D-Cit6, D-Ala10] LHRH.
Csernus VJ; Szende B; Groot K; Redding TW; Schally AV
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):111-8. PubMed ID: 2110458
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.
Szende B; Zalatnai A; Schally AV
Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1643-7. PubMed ID: 2564204
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of somatostatin analogs on prolactin secretion in rats pretreated with estrogen or haloperidol.
Karashima T; Schally AV
Proc Soc Exp Biol Med; 1987 May; 185(1):69-75. PubMed ID: 2883661
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement.
Zalatnai A; Schally AV
Int J Pancreatol; 1989 Mar; 4(2):149-60. PubMed ID: 2566638
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.
Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490
[TBL] [Abstract][Full Text] [Related]
17. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin.
Banks WA; Schally AV; Barrera CM; Fasold MB; Durham DA; Csernus VJ; Groot K; Kastin AJ
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6762-6. PubMed ID: 1975697
[TBL] [Abstract][Full Text] [Related]
18. Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone.
Paz-Bouza JI; Redding TW; Schally AV
Proc Natl Acad Sci U S A; 1987 Feb; 84(4):1112-6. PubMed ID: 2881296
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.
Nagy A; Schally AV; Halmos G; Armatis P; Cai RZ; Csernus V; Kovács M; Koppán M; Szepesházi K; Kahán Z
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1794-9. PubMed ID: 9465096
[TBL] [Abstract][Full Text] [Related]
20. Targeting peptides for pleural cavity tumor radiotherapy: specificity and dosimetry of Re-188-RC-160.
Zamora PO; Bender H; Knapp FF; Rhodes BA; Biersack HJ
Hybridoma; 1997 Feb; 16(1):85-91. PubMed ID: 9085134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
